Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Spark Therap (ONCE)

Spark Therap (ONCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,281,445
  • Shares Outstanding, K 38,523
  • Annual Sales, $ 64,730 K
  • Annual Income, $ -78,820 K
  • 60-Month Beta 2.05
  • Price/Sales 65.86
  • Price/Cash Flow N/A
  • Price/Book 12.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.33
  • Number of Estimates 4
  • High Estimate -0.91
  • Low Estimate -1.84
  • Prior Year -1.75
  • Growth Rate Est. (year over year) +24.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.25 +2.43%
on 12/04/19
112.50 -0.53%
on 11/19/19
+0.32 (+0.29%)
since 11/08/19
3-Month
95.92 +16.66%
on 10/02/19
112.89 -0.88%
on 11/05/19
+10.16 (+9.99%)
since 09/10/19
52-Week
34.53 +224.07%
on 12/26/18
114.20 -2.01%
on 03/12/19
+70.44 (+169.90%)
since 12/10/18

Most Recent Stories

More News
Week Begins with Biotech Mergers

Week Begins with Biotech Mergers

SNY : 48.09 (+6.16%)
MRK : 89.10 (+0.43%)
RHHBY : 38.4000 (+0.01%)
THOR : 67.80 (+0.13%)
ONCE : 111.90 (+0.68%)
ARQL : 19.95 (+1.27%)
Merger Monday, Biotech Edition: MRK, SNY, ARQL, THOR & More

Large-cap pharmaceutical companies are putting their assets to work in the biotech space, particularly in cancer treatment (oncology).

MRK : 89.10 (+0.43%)
RHHBY : 38.4000 (+0.01%)
SNY : 48.09 (+6.16%)
THOR : 67.80 (+0.13%)
ONCE : 111.90 (+0.68%)
ARQL : 19.95 (+1.27%)
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019

Basel, 9 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced that Roche has extended the offering period of its previously announced...

ONCE : 111.90 (+0.68%)
BioMarin Files MAA to EMA for Gene Therapy of Hemophilia A

BioMarin (BMRN) submits an MAA in Europe for its investigational gene therapy valoctocogene roxaparvovec to treat adult patients with severe hemophilia A.

PFE : 38.48 (+0.42%)
BMRN : 79.43 (+0.67%)
ONCE : 111.90 (+0.68%)
SGMO : 9.06 (-12.17%)
Biogen Ends Enrollment in Eye Disorder Study on Gene Therapy

Biogen (BIIB) completes enrollment in the global phase III STAR clinical study evaluating the gene therapy timrepigene emparvovec for the treatment of a rare, inherited retinal disorder.

BIIB : 297.20 (+0.56%)
ALKS : 21.57 (-0.78%)
ANIK : 55.42 (-0.22%)
ONCE : 111.90 (+0.68%)
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 22 November 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced that Roche has extended the offering period of its previously announced...

ONCE : 111.90 (+0.68%)
Watch for Spark Therapeuti to Potentially Pullback After Gaining 10.82% Yesterday

Spark Therapeuti (NASDAQ:ONCE) traded in a range yesterday that spanned from a low of $108.70 to a high of $110.00. Yesterday, the shares gained 10.8%, which took the trading range above the 3-day high...

ONCE : 111.90 (+0.68%)
Noteworthy Wednesday Option Activity: ONCE, DDD, MAT

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Spark Therapeutics Inc , where a total of 4,526 contracts have traded so far, representing approximately...

ONCE : 111.90 (+0.68%)
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 29 October 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced that Roche has extended the offering period of its previously announced...

ONCE : 111.90 (+0.68%)
Spark Therapeuti Rises 10.75% on Heavy Volume: Watch For Potential Pullback

Spark Therapeuti (NASDAQ:ONCE) traded in a range yesterday that spanned from a low of $108.50 to a high of $109.96. Yesterday, the shares gained 10.8%, which took the trading range above the 3-day high...

ONCE : 111.90 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade ONCE with:

Business Summary

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in...

See More

Key Turning Points

2nd Resistance Point 112.88
1st Resistance Point 112.39
Last Price 111.90
1st Support Level 111.16
2nd Support Level 110.42

See More

52-Week High 114.20
Last Price 111.90
Fibonacci 61.8% 83.77
Fibonacci 50% 74.36
Fibonacci 38.2% 64.96
52-Week Low 34.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar